ABOUT US
NeuralDrive is a Canadian medical device company specializing in the recovery of movement after spinal cord injury.
Through pre-clinical experiments, we demonstrated that neurostimulation through our neural interface can alleviate spinal cord injury deficits and can train the user to regain voluntary control of leg movement even after the stimulation has been turned off.
​
We developed our neural interface to improve rehabilitation through neurostimulation therapies and a neurostimulation optimization module to deliver personalized cortical stimulation during motor training.
Our device enables clinicians to perfectly tailor neurostimulation to their patient's unique characteristics.
​
1
Spinal cord injury per minute worldwide
7000/year
Individuals diagnosed with paraplegia in the U.S, Canada and Europe
15,000/year
370,000 people
Individuals diagnosed with tetraplegia in the U.S, Canada and Europe
Living with spinal cord injury in the U.S and Canada
2,000,000$
lifetime direct health costs for spinal cord injury patients
50,000$
Average indirect costs per individual
70%
Of the clinical population with incomplete paraplegia and tetraplegia
Chip
A chip in the motor cortex
Stimulation
Stimulating at the right time and place
Neuroplasticity
Training neuroplasticity
Recovery
Fostering recovery